IVALUE
IVALUE
Each stock's 10,000-path forecast, rendered as light.
IVALUE (IVALUE) Stock Analysis & Case Study
Is IVALUE a good buy? The data-driven verdict.
IVALUE (IVALUE) trades at ₹278,on the numbers it worth a closer look, a Downstox Snapshot Score of 62/100.
On the numbers, IVALUE (IVALUE) worth a closer look, a Downstox Snapshot Score of 62/100, weighing inexpensive at 14.9× earnings, ROE of 19.8%, a 37% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
IVALUE fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is IVALUE overvalued? IVALUE P/E vs its sector
IVALUE's P/E of 14.9× sits above the sector peer median of 14.9×, so on earnings it screens in line with peers.
IVALUE share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 0.7y of IVALUE history (-5%/yr drift, 44%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| IVALUE 2027 | ₹135 | ₹235 | ₹412 | -14% |
| IVALUE 2028 | ₹92 | ₹203 | ₹459 | -26% |
| IVALUE 2029 | ₹66 | ₹175 | ₹473 | -36% |
| IVALUE 2030 | ₹50 | ₹152 | ₹480 | -44% |
| IVALUE 2031 | ₹38 | ₹132 | ₹466 | -51% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability IVALUE goes up, or doubles?
The bull case for IVALUE
- Trades at just 14.9× earnings, below the ~22× long-run Nifty average, so the valuation leaves room rather than pricing in perfection.
- High return on equity (19.8%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise.
- Strong ROCE (25.1%) shows the core business earns well above its cost of capital.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹473.
The bear case & risks
- A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.
- The probability model is cautious 12 months out, only a 37% chance of finishing above today's price.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹66.
IVALUE volatility & expected range, how bumpy is the ride?
Over the last 0.7 years IVALUE compounded at -5%/year with annualized volatility of 44%. That volatility implies a 1-year 80% range of ₹135–₹412, the honest backbone behind any single price target.
IVALUE price forecast, the full 60-month probability fan
IVALUE price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds IVALUE hits common targets within the simulated horizon?
Full multi-horizon detail on the IVALUE price target & forecast page.
IVALUE Piotroski F-Score: 3/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. IVALUE scores 3/9,weak on the financial-strength checks.
IVALUE MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy IVALUE with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| ZerodhaCHEAPEST | 31.4% | 3.2× |
| Dhan | 50.0% | 2.0× |
Compare every broker on the IVALUE MTF page.
IVALUE vs peers,sector comparison
About IVALUE: sector, index & market-cap context
IVALUE (IVALUE) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹1,518 Cr. See more Nifty 500 stocks.
How the IVALUE Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of IVALUE's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
IVALUE analysis, FAQs
Is IVALUE (IVALUE) a good buy?
On the numbers, IVALUE (IVALUE) worth a closer look, a Downstox Snapshot Score of 62/100, weighing inexpensive at 14.9× earnings, ROE of 19.8%, a 37% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is IVALUE overvalued or undervalued?
IVALUE trades at 14.9× earnings versus a peer median of 14.9×, so it screens richer than its sector peers.
What is the IVALUE share price target for 2031?
IVALUE's probability-weighted 2031 median target is ₹132, with an 80% range of ₹38–₹466 (10,000-path Monte-Carlo).
What is the probability IVALUE doubles in 5 years?
The modelled probability of IVALUE reaching ₹545 (2×) within 5 years is 8%.
What is the bull case for IVALUE?
Trades at just 14.9× earnings, below the ~22× long-run Nifty average, so the valuation leaves room rather than pricing in perfection. High return on equity (19.8%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise. Strong ROCE (25.1%) shows the core business earns well above its cost of capital.
What are the risks in IVALUE?
A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing. The probability model is cautious 12 months out, only a 37% chance of finishing above today's price.